Skrzypczyk, P.; Ofiara, A.; Szyszka, M.; Stelmaszczyk-Emmel, A.; Górska, E.; Pańczyk-Tomaszewska, M.
Serum Sclerostin Is Associated with Peripheral and Central Systolic Blood Pressure in Pediatric Patients with Primary Hypertension. J. Clin. Med. 2021, 10, 3574.
https://doi.org/10.3390/jcm10163574
AMA Style
Skrzypczyk P, Ofiara A, Szyszka M, Stelmaszczyk-Emmel A, Górska E, Pańczyk-Tomaszewska M.
Serum Sclerostin Is Associated with Peripheral and Central Systolic Blood Pressure in Pediatric Patients with Primary Hypertension. Journal of Clinical Medicine. 2021; 10(16):3574.
https://doi.org/10.3390/jcm10163574
Chicago/Turabian Style
Skrzypczyk, Piotr, Anna Ofiara, Michał Szyszka, Anna Stelmaszczyk-Emmel, Elżbieta Górska, and Małgorzata Pańczyk-Tomaszewska.
2021. "Serum Sclerostin Is Associated with Peripheral and Central Systolic Blood Pressure in Pediatric Patients with Primary Hypertension" Journal of Clinical Medicine 10, no. 16: 3574.
https://doi.org/10.3390/jcm10163574
APA Style
Skrzypczyk, P., Ofiara, A., Szyszka, M., Stelmaszczyk-Emmel, A., Górska, E., & Pańczyk-Tomaszewska, M.
(2021). Serum Sclerostin Is Associated with Peripheral and Central Systolic Blood Pressure in Pediatric Patients with Primary Hypertension. Journal of Clinical Medicine, 10(16), 3574.
https://doi.org/10.3390/jcm10163574